[Reducing obesity].
Philippe
P
Letonturier
D000293:Adolescent; D000328:Adult; D001067:Appetite Depressants / Q000627:therapeutic use; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000453:epidemiology; D002648:Child; D003503:Cyclobutanes / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008019:Life Style; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control* / Q000601:surgery; D010880:Piperidines / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D000077285:Rimonabant; D012307:Risk Factors; D011795:Surveys and Questionnaires; D015431:Weight Loss
D001067:Appetite Depressants; D003503:Cyclobutanes; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant; C058254:sibutramine